Tenderwize
Retour à la recherche

Open house drug discount agreements Tolterodin, ATC G04BD07

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Apr 05, 2027 · 219 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tolterodin, ATC G04BD07

40/100

Score d'opportunité

Needs reviewLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

40 / 100

Complexité

20 / 100

Facteurs de risque

No estimated contract value or maximum framework amount is disclosed, making it impossible to assess the potential reve...

If a competitive discount contract for the same active ingredient is concluded, the open-house agreement automatically...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of Tolterodin (ATC G04BD07) pharmaceutical products under non-exclusive discount agreements with AOK Bayern.
Afficher le résumé complet

Open-house model for non-exclusive drug discount agreements for Tolterodin (ATC G04BD07) with AOK Bayern. All qualified pharmaceutical companies can join. No estimated value provided. Contract period: 1 June 2025 to 31 May 2027. Submission deadline: 5 April 2027. Single lot.

Risques

No estimated contract value or maximum framework amount is disclosed, making it impossible to assess the potential reve...

If a competitive discount contract for the same active ingredient is concluded, the open-house agreement automatically...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies are eligible.

Administrative

  • Must submit signed declaration of reliability.
  • Contracts must be submitted in duplicate if in paper form, or electronically with qualified electronic signature.

Critères d'attribution

Lot 1

No award criteria provided (open-house, no selection).

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house drug discount agreements Tolterodin, ATC G04BD07

Non-exclusive discount agreements for Tolterodin (ATC G04BD07). All qualified pharmaceutical companies can join at any time during the contract period.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria provided (open-house, no selection).

Date limite

Deadline Apr 05, 2027

Détails de la procédure

Date de publication
15 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
249772-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30